Anti-SRSF2 antibody (1-100) (STJ25505)

SKU:
STJ25505
£112.50 - £524.50
Free Shipping
Processing The item has been added

Host: Rabbit
Applications: WB/IHC-P/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality : Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.09% Sodium Azide, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:2000
IHC-P:1:50-1:200
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: SRSF2
Gene ID: 6427
Uniprot ID: SRSF2_HUMAN
Immunogen Region: 1-100
Specificity: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human SRSF2 (NP_001182356.1).
Immunogen Sequence: MSYGRPPPDVEGMTSLKVDN LTYRTSPDTLRRVFEKYGRV GDVYIPRDRYTKESRGFAFV RFHDKRDAEDAMDAMDGAVL DGRELRVQMARYGRPPDSHH
Post Translational Modifications Extensively phosphorylated on serine residues in the RS domain. Phosphorylated by SRPK2 and this causes its redistribution from the nuclear speckle to nucleoplasm and controls cell fate decision in response to cisplatin treatment. KAT5/TIP60 inhibits its phosphorylation by preventing SRPK2 nuclear translocation. Acetylation on Lys-52 by KAT5/TIP60 promotes its proteasomal degradation. This effect is counterbalanced by HDAC6, which positively controls SRSF2 protein level by deacetylating it and preventing its proteasomal degradation.
Function Necessary for the splicing of pre-mRNA. It is required for formation of the earliest ATP-dependent splicing complex and interacts with spliceosomal components bound to both the 5'- and 3'-splice sites during spliceosome assembly. It also is required for ATP-dependent interactions of both U1 and U2 snRNPs with pre-mRNA. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Binds to purine-rich RNA sequences, either 5'-AGSAGAGTA-3' (S=C or G) or 5'-GTTCGAGTA-3'. Can bind to beta-globin mRNA and commit it to the splicing pathway. The phosphorylated form (by SRPK2) is required for cellular apoptosis in response to cisplatin treatment.
Protein Name Serine/Arginine-Rich Splicing Factor 2
Protein Pr264
Splicing Component - 35 Kda
Splicing Factor Sc35
Sc-35
Splicing Factor - Arginine/Serine-Rich 2
Database Links Reactome: R-HSA-159236
Reactome: R-HSA-72163
Reactome: R-HSA-72165
Reactome: R-HSA-72187
Reactome: R-HSA-72203
Reactome: R-HSA-73856
Cellular Localisation Nucleus
Nucleoplasm
Nucleus Speckle
Phosphorylation By Srpk2 Provokes Its Redistribution From The Nuclear Speckle To Nucleoplasm
Alternative Antibody Names Anti-Serine/Arginine-Rich Splicing Factor 2 antibody
Anti-Protein Pr264 antibody
Anti-Splicing Component - 35 Kda antibody
Anti-Splicing Factor Sc35 antibody
Anti-Sc-35 antibody
Anti-Splicing Factor - Arginine/Serine-Rich 2 antibody
Anti-SRSF2 antibody
Anti-SFRS2 antibody

Information sourced from Uniprot.org